Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 08:25:41 GMT 2023
by
admin
on
Sat Dec 16 08:25:41 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
Protein Sub Type | IGG1 |
Sequence Origin | HUMANIZED MURINE |
Sequence Type | COMPLETE |
Record UNII |
DB1041CXDG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
590517
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C114299
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
GH-35
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
2050232-20-5
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
Belantamab mafodotin
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
10754
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
DB1041CXDG
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
Belantamab Mafodotin
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
2387834
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
m12230
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
1629760-04-8
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
NO STRUCTURE GIVEN | |||
|
DB1041CXDG
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY | |||
|
100000181695
Created by
admin on Sat Dec 16 08:25:41 GMT 2023 , Edited by admin on Sat Dec 16 08:25:41 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
2_22 | 2_96 |
2_148 | 2_204 |
2_224 | 4_214 |
2_265 | 2_325 |
1_148 | 1_204 |
2_371 | 2_429 |
3_23 | 3_88 |
3_134 | 3_194 |
4_23 | 4_88 |
4_134 | 4_194 |
1_224 | 3_214 |
1_230 | 2_230 |
1_233 | 2_233 |
1_265 | 1_325 |
1_371 | 1_429 |
Glycosylation Type | MAMMALIAN, AFUCOSYLATED |
Glycosylation Link Type | Site |
---|---|
N | 1_301 |
N | 2_301 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
CONJUGATE COMPONENT->CONJUGATE |
|
||
|
CONJUGATE COMPONENT->CONJUGATE |
|
||
|
TARGET->CONJUGATED TOXIN |
|
||
|
TOXIN -> CONJUGATE |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|